Going forward, if the institution persistently fails to comply with its state’s minimum nurse-to-patient staffing plans, it could face regulatory fines, enforced corrective actions, external oversight and—should worse ever come to worst—the potential loss of its state license to operate as a hospital.
Late-breaking data out of EuroPCR focused on 420 patients treated with Boston Scientific's new coronary IVL catheter. Overall, the device was found to be both safe and effective for patients with severe CAD.
